Rafael Amado, EVP of R&D and CMO at Allogene Therapeutics, Inc. (ALLO), sold 5,596 shares at $38.05 ($213K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $213k ALLO by EVP of R&D and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.05 | 2,798 | $106K | 50.0% |
| 2 | $38.05 | 2,798 | $106K | 50.0% |
| Total | $38.05 avg | 5,596 | $213K | 100% |
| Filing → |
| ZLAB | SELL | 2026-03-16 | $110K | — | Filing → |
| ZLAB | SELL | 2026-03-05 | $174K | — | Filing → |
| ZLAB | SELL | 2026-01-02 | $188K | — | Filing → |